October 2025
1. DEVITO L, Mohanraj OS, Debnath D, Constantinesco NJ, et al
   Influenza infection exacerbates high-fat diet-induced atherosclerosis in apolipoprotein gene-deficient mice.
   J Immunol. 2025 Oct 30:vkaf276. doi: 10.1093.
   

   >> Share

   
   
2. SILVA-MORAES V, Reis LR, Ross TM
   Comparative analysis of cellular immune responses to four seasonal inactivated influenza vaccines in younger and older adults.
   J Immunol. 2025 Oct 30:vkaf286. doi: 10.1093.
   

   >> Share

   
   
3. BRADLEY MC, Aliyu T, Gray J, Guan T, et al
   Dietary iron deficiency impairs effector function of memory T cells following influenza infection.
   J Immunol. 2025 Oct 29:vkaf291. doi: 10.1093.
   

   >> Share

   
   September 2025
4. BYRNE J, Gaillard CM, Gu L, Garcia-Leon A, et al
   Specific thresholds of circulating antibody titers predict against infection and reduced disease severity in SARS-CoV-2 close contacts.
   J Immunol. 2025;214:2238-2243.
   

   >> Share

   
   August 2025
5. FENG Z, Han S, He Q, Zhao H, et al
   Chemokine (C-X-C motif) ligand 11 is a crucial antiviral modulator that affects viral replication, the IFN-gamma response, and T-cell functions during respiratory syncytial virus infection.
   J Immunol. 2025;214:1982-1999.
   

   >> Share

   
   July 2025
6. AGRAFIOTIS A, Kuhn R, Panetti C, Venerito M, et al
   Clonally expanded IgG, but not IgA, antibody-secreting cells preferentially target influenza nucleoprotein following homologous and heterologous infections.
   J Immunol. 2025 Jul 26:vkaf144. doi: 10.1093.
   

   >> Share

   
   June 2025
7. YANG OO
   The immunopathogenesis of SARS-CoV-2 infection: Overview of lessons learned in the first 5 years.
   J Immunol. 2025;214:1095-1104.
   

   >> Share

   
   May 2025
8. ALLEN JD, Medina JM, Thomas MH, Lynch A, et al
   H3 hemagglutinin proteins optimized for 2018 to 2022 elicit neutralizing antibodies across panels of modern influenza A(H3N2) viruses.
   J Immunol. 2025 May 21:vkaf092. doi: 10.1093.
   

   >> Share

   
   
9. NOURI HR, Schaunaman N, Kraft M, Numata M, et al
   Tollip deficiency enhances mitophagy and reduces STING activation in influenza A virus-infected mice.
   J Immunol. 2025 May 16:vkaf058. doi: 10.1093.
   

   >> Share

   
   April 2025
10. MADRID DMC, Gu W, Karim SJI, Lowke MT, et al
    Single-cell analysis of pig lung leukocytes and their response to influenza infection and oseltamivir therapy.
    J Immunol. 2025 Apr 15:vkaf032. doi: 10.1093.
    

    >> Share

    
    
11. DING C, Chen Q, Shi Y, Liu J, et al
    Impact of CD4+ T cell and TCR repertoires on SARS-CoV-2-Specific antibody responses in PLWH following COVID-19 vaccination.
    J Immunol. 2025 Apr 15:vkae040. doi: 10.1093.
    

    >> Share

    
    
12. HATIPOGLU I, Ainsua-Enrich E, Kadel S, Turner S, et al
    IRF4-regulated transcriptional and functional heterogeneity of lung-resident CD11b+ cDC2 subsets during influenza virus infection.
    J Immunol. 2025 Apr 10:vkaf060. doi: 10.1093.
    

    >> Share

    
    
13. DINANT S, Castille J, Deloizy C, Bruder E, et al
    The prion-family protein Doppel exerts a protective role during influenza virus infection.
    J Immunol. 2025 Apr 9:vkaf031. doi: 10.1093.
    

    >> Share

    
    March 2025
14. RAO AS, Ugwu N, Onufer AP, Kumova O, et al
    Cathelicidin-related antimicrobial peptide (CRAMP) is toxic during neonatal murine influenza virus infection.
    J Immunol. 2025 Mar 18:vkae053. doi: 10.1093.
    

    >> Share

    
    
15. KHAN R, Ji W, Guzman Rivera J, Madhvi A, et al
    A genetically modulated Toll-like receptor-tolerant phenotype in peripheral blood cells of children with multisystem inflammatory syndrome.
    J Immunol. 2025;214:373-383.
    

    >> Share

    
    
16. BURMAS L, Lee WS, Kelly A, Webster R, et al
    Modulation of germinal center and antibody dynamics via ipsilateral versus contralateral immunization against SARS-CoV-2.
    J Immunol. 2025;214:335-346.
    

    >> Share

    
    February 2025
17. WANG M, Liu C, Fan Q, Sun Y, et al
    Rapid clonal expansion and somatic hypermutation contribute to the fate of SARS-CoV-2 broadly neutralizing antibodies.
    J Immunol. 2025;214:278-289.
    

    >> Share

    
    January 2025
18. GROVENSTEIN P, Bhatnagar N, Kim KH, Pal SS, et al
    Influenza 5xM2e mRNA lipid nanoparticle vaccine confers broad immunity and significantly enhances the efficacy of inactivated split vaccination when coadministered.
    J Immunol. 2025;214:104-114.
    

    >> Share

    
    
19. QIAO P, Yue C, Peng W, Liu K, et al
    Precise motif and cross-presentation of coronavirus peptides by feline MHC class I: implications for the mild infection of SARS-CoV-2.
    J Immunol. 2025;214:115-129.
    

    >> Share

    
    November 2024
20. TONG X, Deng Y, Cizmeci D, Fontana L, et al
    Distinct Functional Humoral Immune Responses Are Induced after Live Attenuated and Inactivated Seasonal Influenza Vaccination.
    J Immunol. 2024 Nov 17:ji2200956. doi: 10.4049/jimmunol.2200956.
    

    >> Share

    
    
21. DICK JK, Sangala JA, Krishna VD, Khaimraj A, et al
    NK Cell and Monocyte Dysfunction in Multisystem Inflammatory Syndrome in Children.
    J Immunol. 2024;213:1452-1466.
    

    >> Share

    
    October 2024
22. RAJU N, Kramer KJ, Cavallaro M, Diotti RA, et al
    Multiplexed Antibody Sequencing and Profiling of the Human Hemagglutinin-specific Memory B Cell Response following Influenza Vaccination.
    J Immunol. 2024 Oct 23:ji2400326. doi: 10.4049/jimmunol.2400326.
    

    >> Share

    
    September 2024
23. DRUSKOVIC M, Lucovnik M, Mesaric VA, Kavsek G, et al
    Immune Response to SARS-CoV-2 in Vaccine-naive Pregnant Women: Assessment of IgG and IgA Antibody Profile at Delivery and 42 Days Postpartum.
    J Immunol. 2024 Sep 11:ji2400055. doi: 10.4049/jimmunol.2400055.
    

    >> Share

    
    
24. HOLDER KA, Ings DP, Fifield KE, Barnes DA, et al
    Sequence Matters: Primary COVID-19 Vaccination after Infection Elicits Similar Anti-spike Antibody Levels, but Stronger Antibody Dependent Cell-mediated Cytotoxicity than Breakthrough Infection.
    J Immunol. 2024 Sep 9:ji2400250. doi: 10.4049/jimmunol.2400250.
    

    >> Share

    
    
25. IZADI A, Godzwon M, Soderlund Strand A, Schmidt T, et al
    Protective Non-neutralizing anti-N-terminal Domain mAb Maintains Fc-mediated Function against SARS-COV-2 Variants up to BA.2.86-JN.1 with Superfluous In Vivo Protection against JN.1 Due to Attenuated Virulence.
    J Immunol. 2024;213:678-689.
    

    >> Share

    
    June 2024
26. HE Z, Li W, Zhang M, Huang M, et al
    RNF216 Inhibits the Replication of H5N1 Avian Influenza Virus and Regulates the RIG-I Signaling Pathway in Ducks.
    J Immunol. 2024 Jun 3:ji2300540. doi: 10.4049/jimmunol.2300540.
    

    >> Share

    
    
27. LEIGHTON PA, Ching K, Reynolds K, Vuong CN, et al
    Chickens with a Truncated Light Chain Transgene Express Single-Domain H Chain-Only Antibodies.
    J Immunol. 2024;212:1744-1753.
    

    >> Share

    
    
28. LEE MJ, de Los Rios Kobara I, Barnard TR, Vales Torres X, et al
    NK Cell-Monocyte Cross-talk Underlies NK Cell Activation in Severe COVID-19.
    J Immunol. 2024;212:1693-1705.
    

    >> Share

    
    May 2024
29. BOUCHER J, Gilbert C, Bose S, Tessier PA, et al
    S100A9: The Unusual Suspect Connecting Viral Infection and Inflammation.
    J Immunol. 2024;212:1523-1529.
    

    >> Share

    
    
30. SAITO S, Bozorgmehr N, Sligl W, Osman M, et al
    The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2-Infected Individuals with Severe Disease.
    J Immunol. 2024;212:1540-1552.
    

    >> Share

    
    April 2024
31. BUDYLOWSKI P, Chau SLL, Banerjee A, Guvenc F, et al
    A Significant Contribution of the Classical Pathway of Complement in SARS-CoV-2 Neutralization of Convalescent and Vaccinee Sera.
    J Immunol. 2024 Apr 29:ji2300320. doi: 10.4049/jimmunol.2300320.
    

    >> Share

    
    
32. KUNDURA L, Cezar R, Ballongue E, Andre S, et al
    Low Percentage of Perforin-Expressing NK Cells during Severe SARS-CoV-2 Infection: Consumption Rather than Primary Deficiency.
    J Immunol. 2024;212:1105-1112.
    

    >> Share

    
    
33. ABE K, Beer JC, Nguyen T, Ariyapala IS, et al
    Cross-Platform Comparison of Highly Sensitive Immunoassays for Inflammatory Markers in a COVID-19 Cohort.
    J Immunol. 2024;212:1244-1253.
    

    >> Share

    
    March 2024
34. LI W, Lin Y, Wang X, Yang H, et al
    Chicken UFL1 Restricts Avian Influenza Virus Replication by Disrupting the Viral Polymerase Complex and Facilitating Type I IFN Production.
    J Immunol. 2024 Mar 13:ji2300613. doi: 10.4049/jimmunol.2300613.
    

    >> Share

    
    
35. READ KA, Amici SA, Farsi S, Cutcliffe M, et al
    PRMT5 Promotes T follicular helper Cell Differentiation and Germinal Center Responses during Influenza Virus Infection.
    J Immunol. 2024 Mar 4:ji2300270. doi: 10.4049/jimmunol.2300270.
    

    >> Share

    
    
36. AL-AHMAD A
    Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines".
    J Immunol. 2024;212:753.
    

    >> Share

    
    
37. MAINO A, Amen A, Plumas J, Bouquet L, et al
    Development of a New Off-the-Shelf Plasmacytoid Dendritic Cell-Based Approach for the Expansion and Characterization of SARS-CoV-2-Specific T Cells.
    J Immunol. 2024;212:825-833.
    

    >> Share

    
    February 2024
38. TANDON P, Abrams ND, Avula LR, Carrick DM, et al
    Unraveling Links between Chronic Inflammation and Long COVID: Workshop Report.
    J Immunol. 2024;212:505-512.
    

    >> Share

    
    
39. BRADSHAW CM, Georgieva T, Tankersley TN, Taylor-Doyle T, et al
    Cutting Edge: Characterization of Low Copy Number Human Angiotensin-Converting Enzyme 2-Transgenic Mice as an Improved Model of SARS-CoV-2 Infection.
    J Immunol. 2024;212:523-528.
    

    >> Share

    
    
40. DHANUSHKODI NR, Prakash S, Quadiri A, Zayou L, et al
    Antiviral and Anti-Inflammatory Therapeutic Effect of RAGE-Ig Protein against Multiple SARS-CoV-2 Variants of Concern Demonstrated in K18-hACE2 Mouse and Syrian Golden Hamster Models.
    J Immunol. 2024;212:576-585.
    

    >> Share

    
    
41. KAMMANN T, Gorin JB, Parrot T, Gao Y, et al
    Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional Anomalies.
    J Immunol. 2024;212:389-396.
    

    >> Share

    
    November 2023
42. LOBBY JL, Danzy S, Holmes KE, Lowen AC, et al
    Both Humoral and Cellular Immunity Limit the Ability of Live Attenuated Influenza Vaccines to Promote T Cell Responses.
    J Immunol. 2023 Nov 20:ji2300343. doi: 10.4049/jimmunol.2300343.
    

    >> Share

    
    
43. EVANS JP, Liu SL
    Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies.
    J Immunol. 2023;211:1459-1467.
    

    >> Share

    
    October 2023
44. MA W, Loving CL, Driver JP
    From Snoot to Tail: A Brief Review of Influenza Virus Infection and Immunity in Pigs.
    J Immunol. 2023;211:1187-1194.
    

    >> Share

    
    
45. DIAZ FE, McGill JL
    Modeling Human Respiratory Syncytial Virus (RSV) Infection: Recent Contributions and Future Directions Using the Calf Model of Bovine RSV Disease.
    J Immunol. 2023;211:1180-1186.
    

    >> Share

    
    
46. NOORUZZAMAN M, Diel DG
    Infection Dynamics, Pathogenesis, and Immunity to SARS-CoV-2 in Naturally Susceptible Animal Species.
    J Immunol. 2023;211:1195-1201.
    

    >> Share

    
    
47. ROSENBERG-HASSON Y, Holmes TH, Diray-Arce J, Chen J, et al
    Relationship of Heterologous Virus Responses and Outcomes in Hospitalized COVID-19 Patients.
    J Immunol. 2023;211:1224-1231.
    

    >> Share

    
    September 2023
48. LUCKE J, Heinrich F, Malsy J, Meins N, et al
    Intestinal IL-1beta Plays a Role in Protecting against SARS-CoV-2 Infection.
    J Immunol. 2023;211:1052-1061.
    

    >> Share

    
    August 2023
49. SANDBERG JK, Leeansyah E, Eller MA, Shacklett BL, et al
    The Emerging Role of MAIT Cell Responses in Viral Infections.
    J Immunol. 2023;211:511-517.
    

    >> Share

    
    
50. CAO L, Hui X, Xu T, Mao H, et al
    The RNA-Splicing Ligase RTCB Promotes Influenza A Virus Replication by Suppressing Innate Immunity via Interaction with RNA Helicase DDX1.
    J Immunol. 2023 Aug 9:ji2200799. doi: 10.4049/jimmunol.2200799.
    

    >> Share

    
    July 2023
51. YU H, Worrall LJ, Berger T, Petric M, et al
    Identification of an optimized Receptor-Binding Domain Subunit Vaccine against SARS-CoV-2.
    J Immunol. 2023 Jul 26:ji2300282. doi: 10.4049/jimmunol.2300282.
    

    >> Share

    
    
52. LAW JC, Watts TH
    Considerations for Choosing T Cell Assays during a Pandemic.
    J Immunol. 2023;211:169-174.
    

    >> Share

    
    
53. PONDE NO, Shoger KE, Khatun MS, Sarkar MK, et al
    SARS-CoV-2 ORF8 Mediates Signals in Macrophages and Monocytes through MyD88 Independently of the IL-17 Receptor.
    J Immunol. 2023;211:252-260.
    

    >> Share

    
    June 2023
54. CHEUNG MW, Dayam RM, Shapiro JR, Law JC, et al
    Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases.
    J Immunol. 2023 Jun 16:ji2300190. doi: 10.4049/jimmunol.2300190.
    

    >> Share

    
    
55. MAMBELLI F, Marinho FV, Andrade JM, de Araujo ACVSC, et al
    Recombinant Bacillus Calmette-Guerin Expressing SARS-CoV-2 Chimeric Protein Protects K18-hACE2 Mice against Viral Challenge.
    J Immunol. 2023;210:1925-1937.
    

    >> Share

    
    
56. PAIDI RK, Jana M, Raha S, Mishra RK, et al
    Prenol, but Not Vitamin C, of Fruit Binds to SARS-CoV-2 Spike S1 to Inhibit Viral Entry: Implications for COVID-19.
    J Immunol. 2023;210:1938-1949.
    

    >> Share

    
    
57. NAM H, Koh JY, Jung JH, Jeong H, et al
    Distinctive Dynamics and Functions of the CD4+CD25+FOXP3+ Regulatory T Cell Population in Patients with Severe and Mild COVID-19.
    J Immunol. 2023;210:1687-1699.
    

    >> Share

    
    May 2023
58. PHAN JM, Layton ED, Yu KKQ, Aguilar MS, et al
    Cytotoxic T Cells Targeting Spike Glycoprotein Are Associated with Hybrid Immunity to SARS-CoV-2.
    J Immunol. 2023;210:1236-1246.
    

    >> Share

    
    March 2023
59. FINN CM, Dhume K, Prokop E, Strutt TM, et al
    STAT1 Controls the Functionality of Influenza-Primed CD4 T Cells but Therapeutic STAT4 Engagement Maximizes Their Antiviral Impact.
    J Immunol. 2023 Mar 24:ji2200407. doi: 10.4049/jimmunol.2200407.
    

    >> Share

    
    
60. HEMANN EA, Knoll ML, Wilkins CR, Subra C, et al
    A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity.
    J Immunol. 2023 Mar 20:ji2300026. doi: 10.4049/jimmunol.2300026.
    

    >> Share

    
    
61. VAN DE WALL S, Crooks S, Varga SM, Badovinac VP, et al
    Cutting Edge: Influenza-Induced CD11alo Airway CD103+ Tissue Resident Memory T Cells Exhibit Compromised IFN-gamma Production after In Vivo TCR Stimulation.
    J Immunol. 2023 Mar 13:ji2200931. doi: 10.4049/jimmunol.2200931.
    

    >> Share

    
    
62. ZHAO Y, Xiao W, Wu Y, Fan W, et al
    Parallel T Cell Immunogenic Regions in Influenza B and A Viruses with Distinct Nuclear Export Signal Functions: The Balance between Viral Life Cycle and Immune Escape.
    J Immunol. 2023 Mar 10:ji2200243. doi: 10.4049/jimmunol.2200243.
    

    >> Share

    
    
63. SHAMSELDIN MM, Kenney A, Zani A, Evans JP, et al
    Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology.
    J Immunol. 2023 Mar 6:ji2200297. doi: 10.4049/jimmunol.2200297.
    

    >> Share

    
    February 2023
64. QUINN M, Parra-Rodriguez L, Alsoussi WB, Ayres C, et al
    Persons with HIV Develop Spike-Specific Lymph Node Germinal Center Responses following SARS-CoV-2 Vaccination.
    J Immunol. 2023 Feb 13:ji2200920. doi: 10.4049/jimmunol.2200920.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share